tm logo
OXURION
REGISTERED

on 28 Sep 2021

Last Applicant/ Owned by

OXURION NV

Gaston Geenslaan 13001 Leuven

BE

Serial Number

1906421 filed on 27th Jun 2018

Registration Number

TMA1110380 registered on 28th Sep 2021

Registration expiry Date

28th Sep 2031

Correspondent Address

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

OXURION

Trademark usage description

biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, Read More

Classification Information


Class [005]
Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals and biological materials both as spatially defined arrays and solutions or reagents for medical laboratory use in diagnosing, monitoring, and predicting diseases and for measuring or predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines, pharmaceutical preparations, namely, cardiovascular pharmaceutical preparations, pharmaceutical preparations for ophthalmological use, pharmaceutical preparations for the relief of pain, pharmaceutical preparations for the treatment of blood disorders, pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical eye drops, namely, eye drops.


Classification kind code

11

Class [042]
Scientific and technological services, namely, scientific and technological research in the field of cardiovascular and ophthalmic disease, medicine and research and design of clinical trials relating thereto; industrial analysis of cardiovascular and ophthalmic disease or disorder detection, cardiovascular and ophthalmic disease or disorder prevention, cardiovascular and ophthalmic disease or disorder treatment, and research services in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development; (bio)pharmaceutical product evaluation; research into treatment of cardio vascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals.


Classification kind code

11

Class [044]
Medical services, namely, therapeutic, prognostic and diagnostic testing services in the field of ophthalmic diseases; veterinary services; providing medical advice in the field of ophthalmology and providing veterinary and pharmaceutical advisory and consultancy services; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services.


Classification kind code

11

Mark Details


Serial Number

1906421

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 191
on 21st Jul 2021
Registration Fee Notice Sent
Submitted for opposition 42
on 28th Apr 2021
Advertised
Submitted for opposition 26
on 29th Mar 2021
Approved
Submitted for opposition 27
on 29th Mar 2021
Approval Notice Sent
Submitted for opposition 135
on 30th Oct 2020
Amendment to Application
Submitted for opposition 22
on 27th May 2020
Search Recorded
Submitted for opposition 20
on 27th May 2020
Examiner's First Report
Submitted for opposition 31
on 29th Jun 2018
Formalized
Submitted for opposition 30
on 27th Jun 2018
Filed
Submitted for opposition 1
on 27th Jun 2018
Created